[시장보고서]임상시험 키트 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

임상시험 키트 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Clinical Trial Kits Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

상품코드 : 1672034

리서치사 : Persistence Market Research

발행일 : 2025년 02월

페이지 정보 : 영문 250 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,411,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,823,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,604,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

주요 인사이트

임상시험 키트 시장 규모(2025년) : 21억 달러
시장 규모 예측(2032년) : 47억 달러
세계 시장 성장률(2025-2032년) : CAGR 12.5%

시장 성장 촉진요인:

세계 임상시험 키트 시장은 다양한 환자 집단으로부터 효율적인 데이터 수집을 가능하게 하는 분산형 임상시험(DCT)의 채택 확대 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 만성질환 증가와 의약품 연구에 대한 투자 증가도 시장 확대의 원동력이 되고 있습니다. 또한 샘플 배송의 실시간 추적 및 데이터 수집의 자동화와 같은 디지털 헬스 솔루션의 발전은 임상시험의 신뢰성과 유효성을 향상시키고 있습니다. 보다 신속한 의약품 승인에 대한 수요와 비용 효율적인 시험 방법에 대한 요구도 시장 확대에 기여하고 있습니다.

시장 기회:

임상시험 키트 시장은 기술 발전, 연구 구상의 확대, 임상시험에서 AI의 통합 증가로 인해 큰 성장 기회를 보이고 있습니다. 맞춤형 의료 및 바이오마커 기반 연구에 대한 수요 증가는 특수 임상시험 키트에 대한 새로운 길을 열어주고 있습니다. 또한 제약사와 CRO의 전략적 제휴는 재택 시험 및 하이브리드 시험과 같은 시험 방법의 혁신을 촉진하고 있습니다. 또한 친환경적이고 지속가능한 임상시험 키트의 개발은 세계 지속가능성 목표를 달성하는 데 있으며, 경쟁 우위를 가져다 줄 것입니다.

세계의 임상시험 키트 시장을 조사했으며, 시장 정의와 개요, 시장 성장 촉진요인 및 억제요인, 각종 동향, 시장 기회와 과제, 시장 규모 추이와 예측, 각종 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

시장 점유율 분석
시장 구조
기업 개요(상세 - 개요, 재무, 전략, 최근 동향)
- Azenta Life Sciences
- Q2 Solutions
- Patheon
- LabCorp drug development
- Charles River Laboratories
- LabConnect
- Almac group
- Precision medicine group
- Cerba research
- Alpha Laboratories Ltd
- Marken SAS
- Clinigen

제13장 부록

KSA

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for clinical trial kits. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global clinical trial kits market from 2025 to 2032.

Key Insights:

Clinical Trial Kits Market Size (2025E): US$ 2.1 Bn
Projected Market Value (2032F):US$ 4.7 Bn
Global Market Growth Rate (CAGR 2025 to 2032):12.5%

Clinical Trial Kits Market - Report Scope:

Clinical trial kits play a crucial role in streamlining the process of conducting clinical research by providing pre-packaged materials for sample collection, testing, and data documentation. These kits are essential in decentralized and remote trials, ensuring efficiency, accuracy, and compliance with regulatory standards. The market serves pharmaceutical and biotechnology companies, contract research organizations (CROs), academic institutions, and healthcare providers. Market growth is driven by increasing clinical trials for drug development, the rise in personalized medicine, and technological advancements in remote sample collection.

Market Growth Drivers:

The global clinical trial kits market is propelled by several key factors, including the growing adoption of decentralized clinical trials (DCTs), enabling efficient data collection from diverse patient populations. The rise in chronic diseases, coupled with increasing investments in drug research, fuels market expansion. Additionally, advancements in digital health solutions, including real-time tracking of sample shipments and automated data collection, enhance the reliability and effectiveness of clinical trials. The demand for faster drug approvals and the need for cost-effective trial methodologies further contribute to market growth.

Market Restraints:

Despite its promising growth, the clinical trial kits market faces challenges related to regulatory compliance, logistical complexities, and high operational costs. Stringent regulatory requirements governing clinical trials and the transportation of biological samples increase compliance burdens. Moreover, logistical challenges associated with sample integrity, transportation delays, and storage conditions hinder market efficiency. The high cost of customized trial kits, particularly for rare diseases and niche applications, limits widespread adoption in cost-sensitive markets.

Market Opportunities:

The clinical trial kits market presents significant growth opportunities driven by technological advancements, expanding research initiatives, and the increasing integration of artificial intelligence in clinical trials. The rising demand for personalized medicine and biomarker-based studies creates new avenues for specialized trial kits. Additionally, strategic collaborations between pharmaceutical companies and CROs facilitate innovation in trial methodologies, including home-based and hybrid trials. The development of eco-friendly and sustainable trial kits also offers a competitive advantage in meeting global sustainability goals.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the clinical trial kits market globally?
How are decentralized clinical trials influencing market dynamics?
What role do technological advancements play in improving trial efficiency?
Who are the key players shaping the market, and what strategies are they adopting?
What are the emerging trends and future prospects in the global clinical trial kits market?

Competitive Intelligence and Business Strategy:

Leading players in the global clinical trial kits market, including Thermo Fisher Scientific, Labcorp Drug Development, Almac Group, and Marken, focus on innovation, strategic partnerships, and expansion into emerging markets. These companies invest in automation, AI-driven logistics, and temperature-controlled packaging solutions to enhance sample integrity and trial efficiency. Collaborations with pharmaceutical firms, regulatory bodies, and technology providers facilitate seamless clinical trial execution and market penetration. Additionally, the development of flexible and patient-centric trial kits supports the industry's shift toward decentralized and virtual clinical trials.

Key Companies Profiled:

Thermo Fisher Scientific
Labcorp Drug Development
Almac Group
Marken
PPD Inc.
Medpace Holdings, Inc.
Catalent Pharma Solutions
Parexel International Corporation
Q2 Solutions
ICON plc

Key Segments Covered in Clinical Trial Kits Industry Survey

By Service Type:

Kitting Solutions
Logistics

By Phase:

Phase I
Phase II
Phase III
Phase IV

By Region:

North America
Latin America
Europe
South Asia & Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Clinical Trial Kits Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Service Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis

4. Global Clinical Trial Kits Market Outlook

4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn ) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn ) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn ) Analysis, 2019-2024
- 4.2.2. Current Market Size (US$ Bn ) Analysis and Forecast, 2025-2032
4.3. Global Clinical Trial Kits Market Outlook: Service Type
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn ) Analysis, By Service Type, 2019-2024
- 4.3.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
  - 4.3.3.1. Kitting Solutions
    - 4.3.3.1.1. Drugs Kits
    - 4.3.3.1.2. Sample Collection Kits
  - 4.3.3.2. Logistics
    - 4.3.3.2.1. Transportation
    - 4.3.3.2.2. Warehousing & Storage
    - 4.3.3.2.3. Other Logistics
- 4.3.4. Market Attractiveness Analysis: Service Type
4.4. Global Clinical Trial Kits Market Outlook: Phase
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn ) Analysis, By Phase, 2019-2024
- 4.4.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
  - 4.4.3.1. Phase I
  - 4.4.3.2. Phase II
  - 4.4.3.3. Phase III
  - 4.4.3.4. Phase IV
- 4.4.4. Market Attractiveness Analysis: Phase

5. Global Clinical Trial Kits Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Bn ) Analysis, By Region, 2019-2024
5.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Clinical Trial Kits Market Outlook

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
- 6.2.1. By Country
- 6.2.2. By Service Type
- 6.2.3. By Phase
6.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
- 6.4.1. Kitting Solutions
  - 6.4.1.1. Drugs Kits
  - 6.4.1.2. Sample Collection Kits
- 6.4.2. Logistics
  - 6.4.2.1. Transportation
  - 6.4.2.2. Warehousing & Storage
  - 6.4.2.3. Other Logistics
6.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
- 6.5.1. Phase I
- 6.5.2. Phase II
- 6.5.3. Phase III
- 6.5.4. Phase IV
6.6. Market Attractiveness Analysis

7. Europe Clinical Trial Kits Market Outlook

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Service Type
- 7.2.3. By Phase
7.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
- 7.4.1. Kitting Solutions
  - 7.4.1.1. Drugs Kits
  - 7.4.1.2. Sample Collection Kits
- 7.4.2. Logistics
  - 7.4.2.1. Transportation
  - 7.4.2.2. Warehousing & Storage
  - 7.4.2.3. Other Logistics
7.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
- 7.5.1. Phase I
- 7.5.2. Phase II
- 7.5.3. Phase III
- 7.5.4. Phase IV
7.6. Market Attractiveness Analysis

8. East Asia Clinical Trial Kits Market Outlook

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Service Type
- 8.2.3. By Phase
8.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
- 8.4.1. Kitting Solutions
  - 8.4.1.1. Drugs Kits
  - 8.4.1.2. Sample Collection Kits
- 8.4.2. Logistics
  - 8.4.2.1. Transportation
  - 8.4.2.2. Warehousing & Storage
  - 8.4.2.3. Other Logistics
8.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
- 8.5.1. Phase I
- 8.5.2. Phase II
- 8.5.3. Phase III
- 8.5.4. Phase IV
8.6. Market Attractiveness Analysis

9. South Asia & Oceania Clinical Trial Kits Market Outlook

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Service Type
- 9.2.3. By Phase
9.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
- 9.4.1. Kitting Solutions
  - 9.4.1.1. Drugs Kits
  - 9.4.1.2. Sample Collection Kits
- 9.4.2. Logistics
  - 9.4.2.1. Transportation
  - 9.4.2.2. Warehousing & Storage
  - 9.4.2.3. Other Logistics
9.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
- 9.5.1. Phase I
- 9.5.2. Phase II
- 9.5.3. Phase III
- 9.5.4. Phase IV
9.6. Market Attractiveness Analysis

10. Latin America Clinical Trial Kits Market Outlook

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Service Type
- 10.2.3. By Phase
10.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
- 10.4.1. Kitting Solutions
  - 10.4.1.1. Drugs Kits
  - 10.4.1.2. Sample Collection Kits
- 10.4.2. Logistics
  - 10.4.2.1. Transportation
  - 10.4.2.2. Warehousing & Storage
  - 10.4.2.3. Other Logistics
10.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
- 10.5.1. Phase I
- 10.5.2. Phase II
- 10.5.3. Phase III
- 10.5.4. Phase IV
10.6. Market Attractiveness Analysis

11. Middle East & Africa Clinical Trial Kits Market Outlook

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Service Type
- 11.2.3. By Phase
11.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Service Type, 2025-2032
- 11.4.1. Kitting Solutions
  - 11.4.1.1. Drugs Kits
  - 11.4.1.2. Sample Collection Kits
- 11.4.2. Logistics
  - 11.4.2.1. Transportation
  - 11.4.2.2. Warehousing & Storage
  - 11.4.2.3. Other Logistics
11.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Phase, 2025-2032
- 11.5.1. Phase I
- 11.5.2. Phase II
- 11.5.3. Phase III
- 11.5.4. Phase IV
11.6. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2025
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping by Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Azenta Life Sciences
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Service Types
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. Q2 Solutions
- 12.3.3. Patheon
- 12.3.4. LabCorp drug development
- 12.3.5. Charles River Laboratories
- 12.3.6. LabConnect
- 12.3.7. Almac group
- 12.3.8. Precision medicine group
- 12.3.9. Cerba research
- 12.3.10. Alpha Laboratories Ltd
- 12.3.11. Marken SAS
- 12.3.12. Clinigen

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations

한글목차

목차

제1장 개요

제2장 시장 개요

제3장 부가가치 인사이트

제5장 세계의 임상시험 키트 시장 전망

제5장 세계의 임상시험 키트 시장 전망 : 지역별

제6장 북미의 임상시험 키트 시장 전망

제7장 유럽의 임상시험 키트 시장 전망

제8장 동아시아의 임상시험 키트 시장 전망

제9장 남아시아·오세아니아의 임상시험 키트 시장 전망

제10장 라틴아메리카의 임상시험 키트 시장 전망

제11장 중동 및 아프리카의 임상시험 키트 시장 전망

제12장 경쟁 구도